Literature DB >> 21951010

Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.

Teresa C Frohman1, Scott L Davis, Elliot M Frohman.   

Abstract

Internuclear ophthalmoparesis (INO) is the most common saccadic eye movement disorder observed in patients with multiple sclerosis (MS). It is characterized by slowing of the adducting eye during horizontal saccades, and most commonly results from a demyelinating lesion in the medial longitudinal fasciculus (MLF) within the midline tegmentum of the pons (ventral to the fourth ventricle) or midbrain (ventral to the cerebral aqueduct). Recent research has demonstrated that adduction velocity in MS-related INO, as measured by infrared eye movement recording techniques, is further reduced by a systematic increase in core body temperature (utilizing tube-lined water infusion suits in conjunction with an ingestible temperature probe and transabdominal telemetry) and reversed to baseline with active cooling. These results suggest that INO may represent a model syndrome by which we can carefully study the Uhthoff's phenomenon and objectively test therapeutic agents for its prevention.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2011        PMID: 21951010     DOI: 10.1111/j.1749-6632.2011.06125.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  Uhthoff's phenomena in MS--clinical features and pathophysiology.

Authors:  Teresa C Frohman; Scott L Davis; Shin Beh; Benjamin M Greenberg; Gina Remington; Elliot M Frohman
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

2.  Efferent Inputs Are Required for Normal Function of Vestibular Nerve Afferents.

Authors:  Vishal Raghu; Richard Salvi; Soroush G Sadeghi
Journal:  J Neurosci       Date:  2019-07-08       Impact factor: 6.167

3.  Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.

Authors:  Alessandro Serra; Margaret M Skelly; Jonathan B Jacobs; Mark F Walker; Jeffrey A Cohen
Journal:  Neurology       Date:  2014-06-06       Impact factor: 9.910

4.  Impaired sweating responses to a passive whole body heat stress in individuals with multiple sclerosis.

Authors:  Dustin R Allen; Mu Huang; Iqra M Parupia; Ariana R Dubelko; Elliot M Frohman; Scott L Davis
Journal:  J Neurophysiol       Date:  2017-03-08       Impact factor: 2.714

5.  Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.

Authors:  Ethan Meltzer; Peter V Sguigna; Adnan Subei; Shin Beh; Eric Kildebeck; Darrel Conger; Amy Conger; Marlen Lucero; Benjamin S Frohman; Ashley N Frohman; Shiv Saidha; Steven Galetta; Peter A Calabresi; Robert Rennaker; Teresa C Frohman; Randy H Kardon; Laura J Balcer; Elliot M Frohman
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

6.  Acute Thermoregulatory and Cardiovascular Response to Submaximal Exercise in People With Multiple Sclerosis.

Authors:  Elisa Gervasoni; Rita Bertoni; Denise Anastasi; Claudio Solaro; Rachele Di Giovanni; Erica Grange; Hanns-Christian Gunga; Marco Rovaris; Davide Cattaneo; Martina Anna Maggioni; Giampiero Merati
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

7.  Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.

Authors:  Lindsay Horton; Amy Conger; Darrel Conger; Gina Remington; Teresa Frohman; Elliot Frohman; Benjamin Greenberg
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

Review 8.  Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms.

Authors:  Aikaterini Christogianni; Richard Bibb; Scott L Davis; Ollie Jay; Michael Barnett; Nikos Evangelou; Davide Filingeri
Journal:  Temperature (Austin)       Date:  2018-09-05

Review 9.  Uhthoff`s phenomenon 125 years later - what do we know today?

Authors:  J A Opara; W Brola; A A Wylegala; E Wylegala
Journal:  J Med Life       Date:  2016 Jan-Mar

10.  Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial.

Authors:  Kawita M S Kanhai; Jenny A Nij Bijvank; Yorick L Wagenaar; Erica S Klaassen; KyoungSoo Lim; Sandrin C Bergheanu; Axel Petzold; Ajay Verma; Jacob Hesterman; Mike P Wattjes; Bernard M J Uitdehaag; Laurentius J van Rijn; Geert Jan Groeneveld
Journal:  CNS Neurosci Ther       Date:  2019-02-12       Impact factor: 5.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.